Because non-profit specific content has a comparatively high news value, the Institute recognizes that the press may play a significant role in furthering the Institute's vision, mission, goals and objectives. The Institute is also cognizant of the following advantages and limitations:
Thus, the Institute is interested in investing time and effort in non-profit media-generating infrastructure by creating a non-profit News Service or/and publishing a Newsletter to generate and distribute sector-wide stories, and assist in distributing Institute's news.
September 23 (released october 4):
Dr. Alain L. Fymat, BA, BS, MA, MS, PhD, PhD is inducted as a Lifetime Member into the "Cambridge Who's Who Executive, Professional and Entrepreneurship Registry". He has been recognized for showing "dedication, leadership and excellence in medical science and technology". To view the complete text , please go to Google.com and Search for : "Cambridge Who's Who Dr Alain L Fymat"
The International Institute of Medicine and Science, Inc. is incorporated in the State of California.
Cambridge Who's Who publishes an update of its October 4, 2008 press release in which it announces the creation of the International Institute of Medicine and Science, Inc. To view the complete text, please go to Google.com and Search for:
" http://www.24-7%20pressrelease.com/press-release/alain-l-fymat-inducted-into-cambridge-executive-professional-and-entrepreneurial-registry-68011.php "
Dr. Gerard Sabbah, DDS is elected Trustee and co-International Director for France and Italy of the International Institute of Medicine and Science, Inc.
Dr. Sabbah completed his dental studies at the University of Nice with added specialization in implantology. For the past twenty years, he dedicated his efforts to accessible and affordable high-quality dental care in France and Italy with a view to impact other European and African countries. He is the Founder and Health Director of "EuroMedicoDentale (EMD), SRL", an international center for facial esthetics, oral and maxillo-facial surgery, and vision correction and rehabilitation.
Dr. Sabbah is the Founder and Vice President of the Association "Drive in Afrika", a French organization headed by Mr. Olivier Stirn (Former Minister and Extraordinary Ambassador in the French Government; Executive Counselor of the Union for a Popular Movement, UPM) that is dedicated to facilitate humanitarian actions initially by French and Italian medico-dental associations in the extension of medicine and dentistry to African nations. He is also Vice President of the Association Italy-Cote d'Azur (France), a trans-border hospital-based organization for French and Italian residents.
As a Board member, Dr. Sabbah will advise the Board at large on all matters relating to the clinical and technological developments in Europe and Africa in dental and oral & maxillo-facial surgery, ophthalmology, and esthetic surgery of the whole face, including new and developing computer-assisted robotic surgery.
Geoff Bond, MS, CEng, MICE, MISE, MIL, MITI, Founding President/CEO of "The Natural Eating Co Ltd", is elected Director/Trustee and International Correspondent in Paphos (Cyprus) of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Mr. Bond, a graduate of London University, spent his early career living and working in remote African villages. Using both research and first-hand observation of tribal societies, he developed the spell-binding story about what it means to be human in nutritional and lifestyle terms. This new science of nutritional anthropology provides an extraordinary understanding of how, by living in harmony with the way our evolutionary history designed us humans, we can rejoice in the best possible health and relish the prospect of a long life lived in good shape.
Today, we can fix just about everything that Nature can throw at us. So what is left are the self-inflicted diseases, the diseases of lifestyle: cancer, heart disease, diabetes, obesity, osteoporosis, arthritis, dementia, and many more. Contrary to what many people believe, they are caused by the mismatch between the lifestyle designed by our evolutionary origins and the lifestyle we live today. They are diseases of modern industrial societies: they were virtually unknown in Prehistoric times.
Mr. Bond is the author of "Natural Eating In a Nutshell", "Natural Eating: Nutritional Anthropology, Eating in Harmony with Our Genetic Programming", and "Deadly Harvests: The Intimate Relationship Between Our Health and Our Food". In these works, he describes the science behind this knowledge, explains why these problems have arisen, shows that the disorders that plague our society are not inevitable, and offers a blueprint for improving our health, longevity and quality of life. Mr. Bond passionately believes in the insights contained in the science of nutritional anthropolgy and has a driving motivation to stimulate everyone to improve his/her life.
Together with his wife and most passionate disciple, Nicole, he is also the co-author of "Healthy Harvests: Healthy Eating with the Bond Girl", a companion volume that embodies the Bond principles.
Mr. Bond lectures extensively in America and Europe, including Continuing Medical Education (CME) training of medical doctors and medically-sponsored outreach seminars. He is a frequent guest on television and radio shows.
As a Board member, Mr. Bond will advise the Board at large on all matters pertaining to nutritional science and its effects on health and disease.
Raymond Sabbah, MSc is elected Director/Trustee and International Correspondent in Madrid (Spain) of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Mr. Sabbah is a graduate of the French Institut d'Etudes Politiques of Paris (France). After an early career with ONEX, Inc., a commodity trader in both Tel Aviv and Madrid, he became Director of Research for INVERFINANZAS, S.A., a medium-sized brokerage company. He then joined TELERATE, Inc., a global vendor of international financial data and became Managing Director of EFECOM, Inc., a vendor of financial data, news and systems, and a competitor of Reuters (Spain). Subsequently, he became Global Business Development Director for EXCEM, S.A., a diversified international group with markets in developed and emerging economies, including China, Egypt, Spain, France, and Morocco. Mr. Sabbah is currently the CEO of SENAF, S.A., an international electronic trading platform.
As a Board Member, Mr. Sabbah will advise the Board at large in all financial and investment matters.
Sanford Wheeler, CFM, CRPC , CRPS is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
After a very successful professional Australian Football career with the Sydney Swans, Mr. Wheeler held executive positions in both the private and public sectors. He is currently a Senior Financial Advisor, Wealth Management Advisor, and Assistant Vice President of the Merrill Lynch organization, Indian Wells (California) office.
As a Board member, Mr. Wheeler will advise the Board at large on community matters and issues.
Dr. Robert Sabbah, MD, FRCSC is elected Director/Trustee and International Correspondent in Montreal (Canada) of the International Institute of Medicine and Science, Inc. of Rancho Mirage, CA.
Dr. Sabbah completed his medical studies and specialization in obstetrics and gynecology at the Universite de Montreal, and post-doctoral studies in fertility and reproductive endocrinology at McGill University, Montreal. He has continually practiced at Hopital du Sacre-Coeur, Montreal, where he became the Scientific Director and Chief of the OB-GYN Department. He is currently the Chief of Gynecology, Clinical Professor at the Faculty of Medicine of the Universite de Montreal, and further assumes responsibility for continuous medical education at Sacre Coeur, including clinical and surgical education in OB-GYN and laparoscopic surgery, where specialists of international reputation are often invited to participate.
Dr. Sabbah is also in charge of the annual congress of gynecological and perinatal medicine that he organizes at Sacre-Coeur. He is an Associate Member of the Royal College of Surgeons of Canada, was an Examiner for the Royal College in OB-GYN, a Member of the Society of Obstetricians and Gynecologists of Canada and the American Association of Gynecologic Laparoscopists, and a Member and Guest Speaker for the American Society of Minimally Invasive Gynecological Surgery. He participated in the clinical development of new surgical techniques in endometrial ablation and tubal ligation by hysteroscopy.
Dr. Sabbah is a member of the Executive Committee and Vice President of the Association of Obstetricians and Gynecologists of the Quebec Province, and a representative for the Federation of Medical Specialists of Quebec.
As a Board member, Dr. Sabbah will advise the Board at large on all matters relating to the clinical and technological developments in obstetrics and gynecology, including new and minimally invasive surgical techniques.
Dr. Paul A. DeRidder, MD, EMBA, FACS, FICS, DABU, DACPE is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. DeRidder is a board-certified Urologist, having received his medical training at the University of Michigan Medical School. He began his medical and clinical career at the University of California at Irvine, Department of Surgery, Division of Urology. At the St Joseph Hospital in Orange, California, he was Chief of Urology and Vice Chairman of the Department of Surgery, Medical Director of the Lithotripsy Service, and Member-at-Large of the Hospital Executive Committee. During that time period, he was Scientific Advisor to the California Medical Association, President of the California Orange County Urological Society, Member of the Medical Review and Advisory Council of the California Orange County Medical Association, Delegate to the Orange County Health Planning Council, and Program Director of the Clinical Urodynamics Seminar.
Dr. DeRidder has extensive experience in managed care as President/CEO of the Urology Specialists Medical Group of Orange County, California, Inc., and President/CEO of the Orange County Specialty Care Medical Group, Inc., Co-Founder and Member of the Board of Directors of Urotherapies, Inc, and Co-Founder and Medical Advisor of the Vandalay Corporation.
Additionally, Dr. DeRidder has considerable experience in the business sector. At the Paul Merage School of Business of the University of California at Irvine, he was a Member of the Executive Committee of the Corporate Partners Program and a Member of the Executive Committee and Charter Member of the Dean's Leadership Council. He is a Founding Shareholder and Advisor of Pan Pacifica, Inc., Board Advisor to Nextphase, Inc., Board Advisor to Women Executives and Entrepreneurs, Vice-Chair of the Board of Directors of SABPA, Director of Numitra Biosciences, and Chairman and Member of the Scientific Advisory Board of Orange County Medical Ventures Incubators (OCBN, Venture Farm, PCPGI, Inc., 4Medica, Tagnos, and Alpine Biomed, Inc.). He is also a Member of the Executive and Education Committees and Head of the Health Care Task Force of Tech Coast Angels, an early-stage investment group, and a Venture Partner of Crystal Cove Capital , a merchant bank in the healthcare and technology sectors. Dr. DeRidder is also an active participant in numerous investment forums extending from California to China. He is also a Life Science Partner and a Member of Ampleluck International Capital Group of Beijing.
As a Board Member, Dr. DeRidder will advise the Board at large on all matters relating to the clinical and technological developments in urology, including the spinning off of new technologies to be developed at the Institute.
(For more information, go to: www.paulderiddermd.com)
Dr. Denise Barbut, MD, MRCP, is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Barbut completed her medical studies at the University College Hospital, London (England). After completing a first residency in Internal Medicine, she practiced at several London hospitals (Hammersmith Hospital; Royal Postgraduate Medical School in renal medicine; National Hospital for Nervous Diseases in neurology;, Brompton Hospital in thoracic medicine; Northwick Park Hospital in endocrinology, dermatology, and general medicine; Atkinson Morley in neurosurgery). She completed a second residence in Neurology at the Medical College of Cornell University, New York and the Sloan Kettering Cancer Center, and received Fellowship training at Cornell in Cognitive Neuroscience and Stroke Medicine.
Dr. Barbut subsequently joined the academic ranks of Cornell University Medical College and The New York Hospital to become Associate Professor of Neurology, Associate Attending Neurologist, Director of the Stroke Research Program , and Director of the Vascular Laboratory. She was also Guest Faculty or Visiting Professor at several medical institutions across the U.S., including John Hopkins University and Harvard University.
Dr. Barbut has extensively published (in excess of 150 articles) and is the author or lead author of over 200 issued or pending U.S. patents relating mostly to methods and devices for neuroprotection.
Dr. Barbut has considerable expertise in medical entrepreneurship, being the Founding Chairman and Head of the Scientific Advisory Boards of five medical, medical device, and pharmaceutical companies, which are currently in later stages of venture capital funding.
In her added role at this Institute, Dr. Barbut will advise the Board at large on all matters relating to clinical and technological developments in neurology and neurological protection, novel neuroprotective medical methodologies and technologies, and the spinning off of new technologies to be developed at the Institute.
The Franco-Italian Association "Drive in Afrika" holds its inaugural meeting at the City Hall of Nice (France). Our Director, Dr. Gerard Sabbah, DDS is its initiator and Co-Founder (see above press release of January 11, 2009). The Association groups mostly physicians and dental surgeons from the French Riviera and Italy. It has two main objectives: (1) Train physicians, nurses and other medical professionals in Nice so as to enable them to effectively treat their patients (children, particularly) in their home countries; and (2) Provide them the required medical equipment. The Association strives to fill the medical needs in orthopedics, dental implantology, cardiology, and ophthalmology (particularly, treatments of glaucoma and cataracts that wreak havoc in African populations and lead to blindness).
The Franco-Italian Association "Drive in Afrika" holds a Colloquium on Ethics at the Carlton Hotel in Cannes, France with more than 30 attendees. Its program featured the following presenters and topics:
Dr. Gerard Sabbah, DDS, initiator and Co-Founder of the Association, and Director/Trustee of the International Institute of Medicine and Science, Inc., Rancho Mirage, California: Ethics and Humanitarian Service;
Mr. Alain Dorison, Inspector General, French Ministry of Finances: Ethics and Economy;
The Honorable Olivier Stirn, Former French Minister, First Counselor to the President of France: Ethics and Politics; and
Dr. Gilles Bernheim, Grand Rabbi of France : Ethics and Judaism.
The Colloquium was attended by 250 personalities representing the world of ethics in France.
Dr. Peter M. Scheer, MS, DDS, is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Scheer received his oral and maxillofacial surgery training at the Loma Linda University, School of Dentistry in Loma Linda, California. He is a Diplomate of the American Board of Oral & Maxillofacial Surgery and a Diplomate of the American Academy of Cosmetic Surgery. He is a well established expert in orthognatic surgery. Nearly 25 years ago, he founded the Mirage Center for Aesthetic Concepts in Rancho Mirage, California, a multi-specialty clinic with fully accredited operating suites including capability for general anesthesia.
Dr. Scheer continues to practice at his world renown Center. He is also on staff at the Eisenhower General Hospital and Medical Center in Rancho Mirage, California, and is a member of the Trauma Team at Desert Regional Hospital in Palm Springs, California. He lectures regularly at the Loma Linda University, School of Dentistry, and internationally including in Japan for implant dentistry and bone healing. He also trains medical and dental professionals at their home institutions and in his Center.
Dr. Scheer grew up in Switzerland and spent eight years in Hamburg, Germany. For the past two decades, he has been a Faculty Member of the Allgemeines Krankenhaus der Stadt (AKS, Wien), Vienna General Hospital and University Clinic, which is the largest hospital in Austria. He teaches its students and residents, and has offered a number of them six-month internships in his Rancho Mirage clinic and offices to learn his specialized cosmetic facial techniques. As a member of the Flying Samaritans, Dr. Scheer undertakes regular annual mission trips to Central America and other parts of the world, including Kazakhstan, to treat children with cleft lips, palates, and patients with other deformities.
As a Board member, Dr. Scheer will advise the Board at large on all matters relating to clinical developments in oral & maxillo-facial surgery and orthognatic surgery, including developments of novel methodologies and techniques.
(For more information, please consult: www.miragesurgery.com)
Institute Director Dr. Peter M. Scheer, MS, DDS completed his annual humanitarian mission in Costa Rica and Kazakhstan to repair and correct cleft lips and palates and other facial deformities of the indigeneous population.
July - September:
On behalf of the Institute, Dr. Alain L. Fymat, MA, MS, PhD, PhD visited several Universities, University hospitals, medical centers, and medical and dental offices in Canada (Montreal and environs), France (Nice and environs), and Italy (San Remo, Arma Di Taggia). The purpose of these visits was to co-opt the affiliation with the Institute of prominent international scientists, physicians, and dental surgeons. The Canada visit was organized by Institute Director, Dr. Robert Sabbah, MD, FRCSC . It included the University du Quebec A Montreal (UQAM) with a session with Dr. Richard Beliveau, PhD (see Press Release below). The France-Italy visits were organized by Institute Director, Dr. Gerard Sabbah, DDS. The visits included: institutions "EuroMedicalDentale" and "Drive in Afrika", and medical and dental centers including sessions with Dr. Gerard Sabbah, DDS, Dr. Gianfranco Trapani, MD, Dr. Mauricio Del Torto, PharmD, Dr. Jean-Louis Roche, DDS(of Cabinet Dentaire Atoll Beach), and Dr. Denis Boucq, MD(of Clinique Mozart and Institut Mozart) (see Press Releases below). In addition, Dr. Samuel Berdugo, MD, MD, organized other visits in Nice, France, particularly of the University de Nice and its Centre Hospitalier Universitaire (CHU), Pediatrics Department, Units of Hematology, Immunology and Cancerology, including sessions with Dr. Herve Haas, MD, Dr. Anne Deville, MD, and Dr. Christine Soler, MD (see Press releases below).
Dr. Richard Beliveau, PhD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Beliveau received his PhD degree from Universite Laval, Laval, Quebec, Canada and pursued post-doctoral training at Cornell University, NY. He currently holds the Chair for Cancer Treatment at Universite du Quebec a Montreal (UQAM) and has been a Professor in its Biochemistry Department since 1984. He is the author of over 380 communications and 240 scientific articles in several learned journals including Lancet, Blood, Journal of Biological Chemistry, and Cancer Research. Todate, he has mentored close to 30 PhD and 70 Master students. He is also an Associate Professor in the Department of Surgery at Universite de Montreal.
Dr. Beliveau is a member of the Neurosurgery-Oncology Division at Centre Hospitalier de l'Universite de Montreal (CHUM), and holder of the Chair of Neurosurgery Claude-Bertrand. He is also a member of the MCETC at the Jewish General Hospital, Montreal.
Dr. Beliveau has been the recipient of approximately 40 grants so far throughout his career. He is currently funded by NSERC, CHIR, the Cancer Research Society, the Charles-Bruneau Foundation, and the UQAM Foundation.
The fight against cancer is at the heart of Dr. Beliveau's scientific and humanitarian concerns. His team, comprised of 30 people, works on 3 main projects: brain tumors and the blood-brain barrier, tumor vascularization (angiogenesis), and prevention of cancer through nutrition (nutraceuticals). He is the author of the best-sellers "Food to Fight Cancer", "Cooking with Food that Fight Cancer", and "Eating Well, Living Well: Everyday Preventive Medicine".
As a Board member, Dr. Beliveau will advise the Board at large on all matters relating to biochemistry, cancer, neurosurgery-oncology, and related novel methodologies and technologies.
Institute Director Geoff Bond, MS, CEng, MICE, MISE, MIL, MITI, was a keynote speaker at the "2009 London Anti-Ageing Conference" held September 11-13, 2009 at the Royal Marsden Education and Conference Centre, Stewarts Grove, South Kensington, London, England. The Conference was organized by Maria Somers and promoted by Ms. Heather Bird, Founder and President of the HB Health Clinics of Knightsbridge, London. It was aimed at health professionals and was accredited for Continuing Professional Development (CPD). The Conference was attended by some 27 specialists from around the world.
The title of Mr. Bond's lecture was: "Latest Insights on Ageing from our Evolutionary History". In this presentation, he advanced the thesis that our current lifestyle is in sharp discordance with our ancestrally hard-wired lifestyle, and this mismatch disturbs many physiological and psychological processes. Realigning our lifestyle today as closely as possible to our Pleistocene-bred natures will support the reversal of degenerative diseases. In addition, Mr. Bond held a two-hour workshop on the subject.
Dr. Herve Haas, MD, is elected Director/Trustee and International Correspondent of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Haas received his medical degree in 1992 together with a Diplome d'Enseignement Superieur (specialty) in Pediatrics, including clinics in the Service of Pediatric Emergencies of the Hopital Cimiez in Nice, France. He also received from the Universite de Nice Sofia-Antipolis a Diplome Universitaire d'Antibiologie in 1995, a Diplome Inter-Universitaire de Pathologie Infectieuse Pediatrique (Universites de Tours, Poitiers, Angers) in 1996, and a Diplome Universitaire de Biologie et Medecine du Sport in 1997. His hospital responsibilities at the Centre Hospitalier Universitaire (CHU) de Nice, Hopital de l'Archet, include: Chief of the Pediatric Emergencies Service , where he has created and coordinates a specialized center for children who are victims of mistreatment, a pediatric unit for physiology and sports medicine, and participation in pediatric reanimation.
Dr Haas also holds from the Universite de Nice, School of Medicine, a Diplome Universitaire d'Algologie, a Diplome Universitaire de Biologie et Medecine du Sport, a Diplome Universitaire de Physiologie et Physiopathologie du Sport, a Diplome Universitaire de Medecine d'Urgence, a Diplome Universitaire d'Infirmiers d'Urgence, a Diplome Inter-Universitaire d'Urgences Pediatriques (Faculties of Clermont-Ferrand, Marseille, Montpelier, and Nice), and a Diplome Inter-Universitaire de Pathologie Infectieuse Pediatrique (Faculties of Nice and Paris). At the Centre Hospitalier Universitaire of Nice, Dr. Haas is also a Membre de la Commission Medicale d'Etablissement since 2006, a Membre du Conseil d'Administration since 2006 and, from 2004-2006, Secretaire Adjoint du Syndicat National des Pediatres des Etablissements Hospitaliers .
Dr. Haas is also a member of several professional societies, including Membre du Bureau du Groupe de Pathologie Infectieuse Pediatrique since 2006, Membre de la Societe Francaise de Pediatrie, Secretaire-Adjoint (1999-2002) and Membre du Conseil d'Administration et de la Commission Scientifique (2000-2005) of the Groupe Francais de Reanimation et d'Urgences Pediatriques. He has published extensively in such prestigious journals as Pediatrie, Archives de Pediatrie, Medecine des Maladies Infectieuses, Revue des Maladies Respiratoires, European Respiration Journal, Revue de Pneumonologie Clinique, Revue Internationale de Pediatrie, Archives de Dermatologie, and many others. He is the author of more than 50 refereed scientific articles and 56 scientific presentations at specialized meetings and symposia. He is a co-Principal Investigator of 7 therapeutic clinical trials and 13 public health studies.
As a Board member, Dr. Haas will advise the Board at large on all matters relating to pediatrics, including infectious pathology, emergency and reanimation, and related advances in clinical practice, methods and technologies.
Dr. Gianfranco Trapani, MD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Trapani graduated cum laude in Medicine and Surgery in 1980, followed by specialization in Pediatrics with honors in 1984, both at the University of Turin, Italy. He has been registered with the Medical Association of Turin from 1980 to 1985, and the Medical Association of Imperia from 1985 to date. Prior to his medical studies, Dr. Trapani graduated in homeopathy, herbal medicine, and oligotherapy in Nice, France. In the care of his patients and their families, he practices integrative medicine.
Dr. Trapani is the Director of the School of Homeopathy, Phytotherapy and Biotherapy for physicians and pharmacists, SMB Italy (www.smbitalia.org). As part of the advanced training in Pediatric Ophthalmology of the Italian Inter-University Consortium (Universities of Turin, Udine, Sassari, Cassino, Macerata, and Molise), Dr. Trapani was Professor of Pediatric Diagnostics (2003-2005). He was Professor at the School of Homeopathy and Phytotherapy of the Society of Biotherapy Medicine (SBM) of Lugano, Switzerland and Turin in 1990-1991 and 1996-1997. He was also Professor of Pediatrics and Child Care at the Nursing School and the School of Midwifery of the University Clinic of Turin. In the years 1989-1991, he directed the School of Homeopathy in Terano and Turin. He was Lecturer in the courses of Phytotherapy, Homeopathy, and Natural Food and Diet Therapy of the Econatura Association of Turin. He taught courses of Homeopahy, Phytotherapy and Biotherapeutics at the School of Homeopathy of the Society of Biotherapy Medicine, Milan from 1989 to 2000.
Dr. Trapani is a teaching consultant to the Chair of Medical Therapy and Thermal Medicine, Center for Research in Bioclimatology and Biotechnology of Natural Medicine. This Center, established by the Faculty of Medicine of the University of Milan, is a World Health Organization (WHO) Collaborating Center for Traditional Medicine, specialization course in unconventional medicine and non-complementary techniques (a three-year module) since 2000.
Dr. Trapani is an expert of the Italian Ministry of Health for the Program of Continuing Medical Education.
Dr. Trapani has published extensively in national and international journals on childhood and infant diseases. He has contributed to several magazines, including the Journal Nature, Unifarma News, Living Healthy and Beautiful, Kitchen and Health, Natural Medicine, Woman and Mother, Modern Woman, and Beneinsieme.
Dr. Trapani has authored 30 books, some of which have been translated in Russian, Czech, Spanih, Arabic, and Hindi.
As a Board member, Dr. Trapani will advise the Board at large on all matters relating to pediatrics and integrative medicine, and related clinical and technological advances.
Dr. Christine Soler, MD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Anne deville, MD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Denis Boucq, MD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Jean-Louis Roche, DDS is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Papa, MD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Mauricio Del Torto, PharmD is elected Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California.
Dr. Gianfranco Trapani, MD, Director/Trustee of the International Institute of Medicine and Science, Inc. of Rancho Mirage, California is elected Academic President of the first Italian School of Classical Osteopathy in Vallecrosia, Italy. The School celebrated its founding the same time the Don Bosco Institute of Italy held its Grand Opening at its facilities. The celebrations were held on December 5, 2009 during an open-day of the Conference entitled "Children's Health and Osteopathy".
(For more information, please visit: www.eico-italia.com)
As an adjunct to this website, Dr. Alain L. Fymat BA, BS, MA, MS, PhD, PhD has created the "socio-professional" network: www.iMedScience.ning.com. This is an interactive network where the Institute's membership (and others) can post blogs, announce events of interest, make comments, suggest ideas or/and topics for further consideration and discussion, etc. iMedScience is different from known social networks (such as LinkedIn, Twitter, etc.) in that it is focused in its scope, aim, and interests. It will allow us to interact with each other in near real-time on subjects of mutual professional interest.
February 10 - March 10:
As in previous years, Institute Director George Bond, MS, CEng. MICE, MISE, MIL, MITI, will be touring Southern California to present a set of lectures on nutrition. His appearances include the following: "Talk of the Desert" with Melinda Read, Time Warner Desert Cities (cable):
The complete schedule includes:
February 26, 10:00 am: Channel 111
February 27, 7:00 pm: Channel 111
February 28, 9:30 am: Channel 111
February 26-March 2: Channel 110 (on demand)
On March 6, he will be the keynote speaker at the Walter T. Stec Memorial Education Foundation Conference titled "Invest now for a lifetime of vibrant health" in Palm Desert, California.
(For more information, see: firstname.lastname@example.org; email@example.com.)
Institute Director Dr. Alain L. Fymat, BA, BS, MA, MS, PhD, PhD is appointed to the Editorial Board of the international "Journal of Nanobiotechnology" (www.jnanobiotechnology.com). The Journal, launched in 2003, accepts manuscripts on all aspects of scientific and technological advances in the fields of medical, biological and nanoscale science. It is an "open access" journal, meaning that published articles are immediately and permanently available on-line. Unrestricted use, distribution, and reproduction in any medium is permitted provided the article is properly cited. It is also an "open data" journal, meaning data in the published articles are available on the public internet permitting any user to download, copy, analyze, pass them to software or use them for any other purpose without financial, legal, or technical barriers.
The Journal is tracked/indexed by PubMed, PubMed central, Thomson Reuters, Biosis, CABI, CAS, EMBASE, Scopus, and Google Scholar.
Dr. Fymat will review appropriate manuscripts submitted to him and will forward them for publication to the Journal.
As in previous years, Institute Director Dr. Gerard Sabbah, DDS is organizing a conference on the complementary theme "Economic Responsibility and Social Ethics". The venue will be the Hotel Carlton in Cannes, France. In addition to Dr. Sabbah, main speakers are:
Mr. Alain Dorrison, General Finance Inspector;
Mr. Christian Ciganer-Albeniz, Administrator, Economist and Financial Consultant; and
Mr. Leo Guez, Educator in Human Resources.
On behalf of the Institute, Dr. Alain L. Fymat, BA, BS, MA, MS, PhD, PhD attended the all-day Workshop "Strategies for Success in a Weak Economy", which was hosted by the Business Technology Center of the Los Angeles County (BTC-LAC) in Altadena, California. The Panel of entrepreneurs and experts included:
Mark Manguera and Caroline Shin-Manguera, Co-Founders, Kogi Corporation;
Phillip Chang, Founder, President and CEO, Yogurtland;
Mark Burson, Managing Director, Burson-Marsteller, a leading public relations and communcations firm;
Dr. Mark Lieberman, Manager, Economic/Redevelopment Division, BTC-LAC;
Christopher J. Husa, Attorney, Locke Lord Bissell, Liddell LLP, a full-service national law firm; and
Cameron Wood, Principal, Kline Hawkes & Co, one of Los Angeles' most established venture firms.
The panel discussed the effects of the current economic climate on new and emerging businesses and suggestions to achieve success. Topics included:
June 9 - 17:
Following a competitive blind review process among ~ 200 applicants, Dr. Alain L. Fymat, BA, BS, MA, MS, PhD, PhD was selected a member of a U.S. Delegation of 15 academicians constituting the Second Summer Faculty Fellowship Institute in Israel, June 9-17, 2010. The Institute was sponsored by "Scholars for Peace in the Middle East (SPME)", "Jewish National Fund (JNF)", "Legacy Heritage Fund (LHF)", and "MediaWatch International (MWI)". Co-hosting Israeli academic institutions were: The Hebrew University of Jerusalem, Tel Aviv University, Ben Gurion University of the Negev, Haifa University, Bar Ilan University, Technion (Israel Institute of Technology), Inter-Disciplinary Center Herzliya, and Sapir College. The tour was led by Professor Samuel Edelman (Executive Director, SPME), Rene Reinhard (Executive Director, JNF), and Sharon Tzur (President/CEO, MWI).
The goal of the Summer Institute was "to link scholars from diverse disciplines with their israeli counterparts at major institutions for the purpose of initiating exchanges and collaborations as well as curricular development".
The delegation visited several historical and other sites: Ohel Yitzchak Synaguogue, Yad Vashem Holocaust Memorial and Museum; Jerusalem Old City and the Western Wall Tunnel; Massada; Dead Sea; Habonim Gardens, Mamilla Mall; 9/11 Memorial; Nazareth; Dalia El-Carmel; Sderot; Old Jaffa (Neve Tzedek); Gaza Border; Bahai Temple/German Colony/Mt Carmel; Ben Gurion House; Palmach House; Tel Aviv Museum and Independence Hall; Atlit; Israel Museum.
The Summer Institute was extremely well organized. It fulfilled its stated objectives of focusing on the following areas: academic exchange, networking and collaboration, history, society, economy, politics, diplomacy and the media, culture, and science and technology. Its selection of Institute Fellows represented an interesting cross-section of U.S. academia. Each of us had the opportunity to connect with israeli professors, experts and professionals involved in government , industry, education, media and other sectors.
Dr. Fymat made personal visits with the following academics:
Prof. A. Mark Clarfield, MD, FRCPC, Head of Geriatrics, Soroka Hospital, Director of the Medical School for International Health, and Sidonie Hecht Professor of Geriatrics, Ben Gurion University of the Negev;
Dr. Michael Elkin, PhD, Hadassah Hospital Ein-Kerem, Sharet Institute, Tumor Biology Research Unit and Hebrew University;
Prof. Abraham Korol, PhD, Director of the Institute of Evolution, Professor of Genetics, Faculty of Science, Haifa University;
Prof. Guy Deutscher, PhD, Specialist in Nanotechnology, School of Physicvs and Astronomy, Tel Aviv University;
Prof. Lev Vaidman, PhD, Specialist in Quantum Theory, School of Physics and Astronomy, Tel Aviv University;
Prof. Yair Aharonowitz, PhD, Former Vice President of Research and Development, Specialist in Microbiology and Biotechnology, School of Physics and Astronomy, Tel Aviv University;
Prof. Benjamin Sredni, PhD, Head, The Sadie AIDS & Immunology Research Program, Head of the Cancer Institute, Founding Dean of the forthcoming new School of Medicine, and Chief Scientist at the Israel Ministry of Health and the Israel National Institute of Health; Specialist in AIDS, Cancer and Immunology, Bar Ilan University;
Dr. Roni Grosz, PhD, Curator of the Albert Einstein Archives, The Hebrew University.
Dr. Michel Elkin, PhD is elected a member of the International Institute of Medicine and Science, Inc. in Rancho Mirage, California.
Dr Elkin graduated from The Hebrew University, Faculty of Medicine in 2000 with field of expertise on tumor biology. After a postdoctoral fellowship at the National Institute of Dental and Craniofacial Research, U.S. National Institutes of Health, 2000-2002, with field of expertise on extracellular matrix and sex steroids, he joined the faculty of The Hebrew University as a Senior Investigator in the Tumor Biology Unit of the Sharett Oncology Institute and the Hadassa Hospital. He was subsequently promoted to Lecturer and Senior Lecturer in Experimental Oncology.
Dr. Elkin is a member of several prominent professional associations, including the American Association for Cancer Research, the European Association for the Study of Diabetes, and the European Association for Cancer Research. He is also an Editorial Board Member of the Scientific World Journal for Neoplasia, Immunology and Cell Biology, and Cancer Research. He is also a reviewer of grants for several foundations: the Wellcome Trust, UK, the German-Israeli Foundation for Scientific Research, the Israel Cancer Foundation, and the National Institute for Biotechnology in the Negev.
Dr. Elkin was the recipient of numerous awards and prizes, and 15 research grants mostly in the areas of cancer and diabetes. He has also published extensively (36 refereed articles).
As a Member of the Institute, Dr. Elkin will advise the Board at large on all matters relating to cancer and diabetes including new protocols, drug developments, and associated biotechnologies.
Director Raymond Sabbah, MSc was selected a Senior Consultant for the London-based Bourse Consult (www.bourse-consult.com) and a member of its team of leading industry experts. Bourse Consult is the leading international capital markets consultancy. All consultants have been either CEOs or senior directors of exchanges or clearing houses.
Since its foundation in 2002, Bourse Consult has been involved in a number of infrastructure projects, including the building of the Dubai International Financial Exchange (now NASDAQ Dubai) and the Hong Kong Mercantile Exchange, and has also published several highly regarded research papers on capital markets issues.
Director Robert Sabbah, MD, FRCSC has been elected Presdient of the prestigious Society of Obstetricians & Gynecologists of the Province of Quebec, Canada. This appointment is for a period of two years. It is an important position in that it will govern the transformation and evolution of that profession in Quebec. It will also be the focal point of interaction with like societies in other provinces of Canada and Canada itself.
February 20 - March 20:
Director Geoff Bond, MS, C.Eng, MICE, MIL, MITI was again invited for a lecture tour of Southern California.
Dr. Eytan Ellenberg, MD, PhD, MBA has joined the International Institute of Medicine and Science in Rancho Mirage, California as Vice President for Business Development.
Dr. Ellenberg earned his MD degree in Public Health and Social Medicine in October 2004 from the University of Paris-Sorbonne ("Nouvelle Sorbonne Paris III"). He also holds a PhD in Medical Linguistics from the same institution, an MBA from the Sorbonne Business School, and an Ultimate CRA Development in Pharmaceutics in 2010. Prior to that, he received a specialized Master degree in Hospital Risk Management from the Ecole Centrale de Paris in 2003 and a Master degree in Biostatistics and Modeling from the University of Paris, Faculty of Medicine Paris VII in 2003.
After several Internships in Public Health (with the French Ministry of Labor and Social Affairs with emphasis in Suicide Prevention and Psychiatry in Prisons, 2000-2001; with the European Hospital Georges Pompidou, with emphasis on Hospital Risk Management and Information Systems, 2001; with the Pediatric Hospital Robert Debre, with emphasis on Accreditation and Hospital Risk Management, 2001-2002; with the Ethical Committee of Hopitaux de Paris with emphasis on research coordination on application of French Law and Ethics and Bioethics in hospitals and Ethics in Europe, 2002-2004, Dr. Ellenberg became research coordinator and lecturer in the Faculty of Medicine, Paris-Sud, Department of Research on Ethics, 2004. He was also Medical Advisor for Arsenal/TBWA WorldHealth, 2004-2006. His charge was in Ethics (neurology, pain, ophthalmology, diabetes, cardiovascular, oncology, dermatology,etc.), Pre-launches and Launches (for Pfizer, Grunenthal, Abott, Schering-Plough, Novartis, and others), and Public Health (healthcare networks, French national insurance). He developed expertise in copyrighting, communication strategy and operational planning, strategic planning, global communication counseling, Key Opinion Leaders' relations and medical education, board organization, public relations, and international communication.
Dr. Ellenberg subsequently became Medical Director of Orkyn" (Home Care provider, and a subsidiary of Air Liquide), 2007-2010. He was responsible for quality of care (protocols, procedures, clinical follow-up of 85,000 patients for sleep apnea, respiratory failure, diabetes, Parkinson, Alzheimer) and supervised 700 home care technicians, nurses and dietitians. He was also responsible for Key Opinion Leaders' relations (in pneumonology, diabetology, neurology), patient education and disease management programs, especially in COPD), and clinical studies (interaction with sales forces, business development, marketing and innovation).
After a sabbatical as a Visiting Professor at the Universidade Federal Do Estado Do Rio de Janeiro-UNIRIO, Brazil, in Medical Linguistics, 2010, he assumed his current position since July 2010 as Medical Director of Air Liquide Sante International ALSI (home care development). He is charged to define and improve the home care positioning of ALSI, develop new indications for oxygen use in neurology and cardiology, define disease management programs, and increase market access.
Dr. Ellenberg has published extensively on clinical and hospital risk management, and bioethics and public health. He is the author of a book on the dangers posed by hospitalization.
In his position as Vice President for Business Development, Dr. Ellenberg is charged to develop this Institute's research, education and service programs on an international scale.
The International Institute of Medicine and Science, Inc. has entered in an agreement with Words4Health to promote its development in research, specialized medical/science education and service to the communities served and to humanity.
Kenneth Kei Adams, MD, DABPM&R is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Adams received his medical education from the University of Texas Southwestern Medical School at Dallas from which he received his MD degree (specialization: Physical Medicine & Rehabilitation - PM&R) in May 1997. He is a Diplomate of the American Board of Physical Medicine & Rehabilitation.
Dr. Adams held several executive positions including: CEO & Medical Director of Vertical Assurance, LLC (2003-2007); CEO & Medical Director of Inpatient Rehabilitation Specialists (since August 2001); Medical Director of PrimeCare Home Health Care (2001-2007); Medical Director of CardioDiagnostic Group (2001-2008); Medical Director of the Inpatient Rehabilitation Unit at the Medical Center of Plano (2003-2005) and at RHD Memorial Hospital (2001-2006); Corporate Medical Director (2005-2006), Chief Medical Officer and Senior Vice President of Medical Affairs (2005-2008) of RehabCare Group; and CEO of Skilled Rehab Specialists (since 2008).
Dr. Adams is a Member of several professional associations: American Academy of Physical Medicine & Rehabilitation (AAPM&R), Health Policy and Legislative Committee (2008) and the only physician on its Technical Expert Panel to Interpret CMS 75/25 rule (2004); National Medical Advisory Board for RehabCare (member since 2004 and chairman in 2005-2008); American Medical Rehabilitation Providers Association (AMRPA), National Clinical Advisory Group (member since 2004, chairman since 2006).
Dr. Adams was Assistant Instructor (2000-2001), Assistant Clinical Professor (2001-2009), Associate Clinical Professor (2010-) of Physical Medicine & Rehabilitation at the University of Texas Southwestern Medical School at Dallas. He was also Chief of Staff at the RHD Memorial Medical Center (2005-2006); Member of the Board of Directors and Treasurer (2003-2007) and Director of Board Expansion of Metrocrest Hospital Foundation (2003-2005); and a member of the Board of Directors of the American Medical Rehabilitation Providers Association (2007-2011).
Dr. Adams has received several honors and awards including "Best Doctors in Dallas" from the D-Magazine (2003 and 2004); "National Medical Director of the Year" from RehabCare (2002); and "Young Physician Award" from the American Medical Association (2003). He has lectured extensively across Texas, and published the first on-line Physiatry textbook. He is a sports team physician and a global volunteer medical staff in countries such as Haiti, China, Venezuela, Belgium, and Cuba.
Dr. Adams will advise the Board at large on all matters relating to physical medicine and rehabilitation including strategic planning and growth, legislative involvement in health care, media relations, and regulatory compliance.
Amir H. Karimzadeh, PharmD, N.Ph. is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Karimzadeh received his Pharmacy degree from the University of Washington, Seattle, Washington, and his degree in Nuclear Pharmacy from the University of Arkansas. He then joined the Good Samaritan Hospital and Medical Center as a Clinical Pharmacist for infectious diseases, nephrology, oncology, cardiology, general medicine and nutritional support teams, 1987-2001. For the period 1999-2000, he also served concurrently as a Clinical Nuclear Pharmacist with Syncor International Corporation. Subsequently, he was appointed Associate Director and Clinical Specialist at Tuality Healthcare, Hillsboro, Oregon, 2000-2002, and Clinical Psychiatric Pharmacist at Tuality Forest Grove Hospital, Forest Grove, Oregon, 2002-2004. He subsequently joined the Forest Research Institute as a Senior Medical Liaison in the Central Nervous System Division, 2002-2005. Thereafter he was appointed Senior Manager at the Allergan Neurosciences Division of Genitourinary Health, Irvine, California, 2005-2006. He then moved to Elan Pharmaceuticals as a Regional Medical Director for Immunotherapy, South San Francisco, 2006-2009. He is currently, and since 2009, Vice President for Medical Affairs and Medical Director at Cory/Paeth Medical Education Group, Chicago, Illinois.
Dr. Karimzadeh is a member of several professional associations, including the American Academy of Medical Directors, the American College of Clinical Pharmacists, and the American Society of Healthcare Pharmacists. He has been active in research and education with several publications and presentations.
Dr. Karimzadeh will advise the Board at large on all matters relating to clinical and nuclear pharmacology including novel methodologies in research and education in these fields.
Robert D. Solomon, MD, DABR joined the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Solomon completed his medical studies at the Boston University School of Medicine, Boston, Massachusetts, in 1988 with honor courses in Pathology, Biology of Disease, Neurology, and Pediatric Radiology. After an Internship at the Monmouth Medical Center, Long Branch, New Jersey, in Internal Medicine in 1989, he completed his Residency in Diagnostic Radiology at the State University of New York Health Sciences Center, Brooklyn, New York, in 1993. He then became Staff Radiologist at the North Shore University Hospital at Glenn Cove, New York, 1993-1994, at the Long Island Diagnostic Imaging, New York, 1994-1995, and at the Parkway MRI, P.C., Brooklyn, New York, 1995-1999. He became Medical Director and Staff Radiologist at Complete Radiology, P.C., Brooklyn, New York, 1998-present and also at the Richmond Radiology, P.C., Brooklyn, New York, since 2001.
Dr. Solomon is a Diplomate of the National Board of Medical Examiners and the American Board of Radiology. He is a member of several professional associations including the Radiological Society of North America and the American College of Radiology. He specializes in most areas of diagnostic radiology (neurology, CT/US/MRI, angiography/interventional, pediatric, mammography, bone densitometry). His two chief interests are in transcranial magnetic stimulation and its improvement of functional MRI, and in medical imaging in drug development trials. His other interests include Telemedicine/Teleradiology.
Dr. Solomon will advise the Board on all matters relating to all modalities of diagnostic radiology as well as new technological developments in these areas.
Dr. Chittarvu Venkatesh, DDS joined the International Institute of Medicine and Science in Rancho Mirage, Caifornia.
Dr. Khartik Anantharaman, MBA, MBBS joined the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Anil V. Arundi, DDS joined the International Institute of Medicine and Science in Rancho Mirage, California.
Director Dr. Alain L. Fymat, BA, BS, MA, MS, PhD, PhD has accepted an invitation from Akademia Kiado (the Hungarian Academy of Medicine and Science, founded in 1828) and Semmelweis University to join the Board of Reviewers of its Interventional Medicine and Applied Sciences Journal. The Journal is hosted by four scientific societies:
The focus of the Journal is to dynamically improve interventional activities in all fields of medicine, including minimally invasive specialties: cardiology, angiology, laparoscopy surgery, invasive radiology, anesthesia and intensive care medicine, as well as all fields of applied sciences. Dr. Fymat will review original submissions in Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics.
Within his institution, Euromedicodentale, SA, Director Dr. Gerard Sabbah, DDS inaugurated his Center for Facial Surgery and Medicine ("Centro di Chirurgia e Medicina del Viso") including implantology, esthetic medicine, and TAC. Dr. Sabbah is now its Chief Executive Officer. Together with his associate, Dr. Claude Schiff, DDS, Dr. Sabbah also inaugurated a Division of Radiology within Euromedicodentale.
Dr. Jean-Philippe Azulay, MD, PhD is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Azulay completed his medical studies and obtained his Physician License from the University of Aix-Marseille II, France, in 1990. That same year, he also obtained his Certification in Neurology by the French Board of Neurology and became a member of the French Board of Physicians. Subsequently, in 1998, he received a PhD in Neurosciences from the same University. Since 1990, Dr. Azulay has been Attending Physician at the University Hospital de la Timone, Marseille, France. In 1999, he became Professor of Neurology at the School of Medicine of Marseille and, since 2007, the Head of its Movement Disorders Unit.
Dr. Azulay is also a Research Scientist with the French National Center for Scientific Research and a Member of the team on Movement Disorders and Developmental Aspects. In these activities, he is often called on to review articles submitted for publication in numerous professional journals, including: Brain, Neurology, Journal of Neurology, Neurology and Psychiatry, Experimental Brain Research, Clinical Neurophysiology, Journal of Neurological Sciences , Revue Neurologique, and Neuroscience Letter. He is also an expert and key opinion leader for drug companies, includingAFSSAPS and ANR. Dr. Azulay is a member of several scientific societies, including: French Neurological Society, French Neurophysiological Society, Movement Disorders Society, and is on the Editorial Board of La Revue Neurologique. He has published over 140 articles and book chapters in the field of neurology and neurological science.
Dr. Azulay has extensive experience in clinical trials having participated or conducted more than 50 such trials with main fields in Parkinson's disease, ALS, atypical parkinsonian syndromes.
In his role as Director/Trustee, Dr. Azulay will advise the Board at large on all matters relating to neurology and neurological science with particular emphasis on movement disorders.
Director, Dr. Alain L. Fymat, BA, BS, MA,. MS, PhD, PhD was invited and accepted the added position of Visiting Consultant at the Interventional Cardiac Centers of India and at the Advanced Center for Cardiovascular Disease and Research, Rockford Hospital, New Delhi, India. In this position, Dr. Fymat will advise the executive management of these Centers on most appropriate ways of implementing and expanding a network of interventional cardiovascular centers within established hospitals across India.
Dr. Narendra Vikramaditya Yadav, MD, MRCP(UK) is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Vikramaditya completed his medical education in 1999 with an MD degree from the Calcutta National Medical College, Calcutta University, one of the oldest and most prestigious medical colleges of India including an 800-bed hospital. He completed Fellowships in Interventional Cardiology (2004), Laser Interventions (2005), Complex Angioplasty (2008) and Remote Magnetic Navigation Systems (2010). He subsequently completed his MRCP (Member, Royal College of Physicians) from St Georges Hospital, London (UK) in 2001. After extensive training in interventional cardiology, he was awarded membership in the British Cardiac Society. In 2002, he joined St. Georges Hospital as an interventional cardiologist. He became Editor and Reviewer of the British Medical Journal. Dr. Vikramaditya also became an International Associate of the American College of Cardiology in 2003. That same year, he joined Escorts Heart Institute in New Delhi, became a Fellow in Complex Angioplasty, Laser Angioplasty, and Rotacs Procedure from Rosalind Franklin University of Medicine and Science, Chicago.
Dr. Vikramaditya returned to India in 2006 and joined the Wockhardt Heart center, Hyderabad, as a Consultant Interventional Cardiologist. He also became reviewer for the International Journal of Cardiology.
Dr. Vikramaditya specializes in conventional angiography and angioplasty, complex coronary interventions, peripheral interventions, pacemaker implantation, ICD implantation, laser intervention device, USG PTCA device, rotablation, rotational atherectomy device, directional atherectomy device, rotacs procedures, intravascular ultrasound, and remote magnetic navigation system. In 2006, he joined the Apollo Group of Central India.
In 2009, Dr. Vikramaditya became Director for Cardiac Sciences at the Cardiac Centre, Ivy Hospital at Mohali and subsequently joined the Fortis Group as Director of its Cardiovasclar Division. In the last 5 years, Dr. Vikramaditya has performed in excess of 1,000 complex angioplasties including left main, TVDs, bifurcations, CTOs and primary angioplasties. Dr. Vikramaditya is associated with Klinikum Nurenberg Hospital, Nurenberg, Germany as a Senior Interventional Cardiologist. In addition, he is also a Visiting Consultant to University Teaching Hospital, Spain, Glasgow Hospital in Scotland, Al Hilal Hospital in Bahrain, and the National Heart Institute, East of Kailash, New Delhi. Dr. Vikramaditya received a number of awards including the Young Cardiologist Award by the Government of Spain (2003) and the Outstanding Service to people Award by the U.S. Government (2005).
In his new role as Director/Trustee, Dr. Vikramaditya will advise the Board at large on new developments in interventional cardiology and will expand the role of the Institute in this important area.
Dr. Bogdan Nicolescu-Catargi, MD, PhD is elected Director/trustee of the International Institute of Medicine and Science, Inc. in Rancho Mirage, California.
Dr. Catargi received his medical degrees from the University Hospital of Bordeaux, France. He is currently a Professor of Medicine in the Department of Endocrinology of that University and a Vice-President of the EVADIAC study group.
Dr. Catargi is involved in clinical research with continuous glucose monitoring and insulin pumps (external and implantable). He has published numerous articles on this subject in the professional literature (Journal of Control Release, Journal of Colloidal Interface Science, Diabetes Metabolism, and Expert Review of Medical Devices). He also holds the French patent (dated January 13, 2010) on a clinical insulin detector including its process of fabrication.
Dr. Catargi is also a consultant to the medical device industry for continuous glucose monitoring devices and insulin pumps (Medtronic, Menarini, Abbott).
In his new role as Director/Trustee, Dr. Catargi will advise the Board at large on new developments in endocrinology and will expand the role of the Institute in this important area.
Dr. Sukesh Trikha (Surg Lt Cdr), MD is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Institute Director, Dr. Gerard Sabbah, DDS and his team (Prof.-Dr. Giuseppe Monetti, MD (musculoskeletal radiologist); Dr. Claude Schiff, DDS; Mrs. Josiane Sabbah, Executive Director) of G3D, a subsidiary of Euro-Medicale, Ltd.) visited PLANMECA in Helsinki, Finland. PLANMECA is the manufacturer of advanced imaging dentistry equipment, including the state-of-the-art Cone Beam Computed Tomography (CBCT) system. PLANMECA was represented by its President/CEO and its Vice President for international relations.
The G3D team proposed a cooperative project aimed at the utilization and global expansion of cone-beam radiological imaging of the complete face for dental implantology, maxillo-facial surgery, facial esthetic & reconstructive surgery, and musculo-skeletal radiology & corrective surgery. A test pilot for the project consists in the development of a mobile radiological unit including a beta version of the Planmeca Promax 3D Pro-face system, a magnetic resonance imaging (MRI) unit, and an ultrasound echo imaging unit.
According to its manufacturer,"the Planmeca Promax 3D Pro-face system is a unique CBCT imaging unit with integrated three-dimensional patient's face scan system that is acquired in a radiation-free process. This true three-dimensional application is designed to fulfill the most diverse diagnostic needs of today's maxillo-facial and dental professionals. It affords the medical or dental professional the opportunity to plan interventions and document the follow-up images. It also enables safer and faster facial surgeries". By augmenting this system with a magnetic resonance imaging unit and an ultrasound echo Doppler unit, the G3D team will additionally be able to provide the optimal diagnosis for osteo-articular pathologies.
Advantages of this project include: (1) Patients are no longer required to visit the diagnostic/treatment centers, the reverse actually takes place; (2) The combined use of the three technologies reinforces diagnostic quality and allows the surgeon to optimize his/her intervention; (3) the radiological report represents the GPS for the surgery, which would enable optimal surgery and post-surgery follow-ups.
The project is jointly sponsored by G3D, the University of Bologna (Italy), School of Musculo-Skeletal Radiology (Director: Professor Giuseppe Monetti, a world leader in static and dynamic radiology) and the International Institute of medicine and Science, Inc..
Dr. Boris Herscovici (Herskowitz), PhD has been appointed International Correspondent of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Herscovici completed his education at theUniversity "Dunarea de Jos", Galati, Romania, initially in the Institute of Food Science and Technology (MSc, Food Engineering, 1977) and subsequently in the Department of Biochemistry, Galati (PhD, Industrial Engineering, 2006). His field of scientific expertise is in food technology and medical nutrition. He has lectured extensively across Europe (Switzerland, Romania, Germany, Italy, Holland, Belgium, United Kingdom, France, Denmark), Minor Asia (Turkey, Israel), and the U.S.
Dr. Herscovici is the co-author of several scientific publications, a book and a patent. He is also a member of several national and international professional societies.
Dr. Herscovici is currently employed by the Technion R&D Foundation Ltd, Liaison Office, National, Bi-Lateral and EUREKA Programs, Haifa, israel.
As a corresponding member, Dr. Herscovici will update the Institute's Board on issues concernant nutritional medicine, lifestyle modifications and age extension. He will also be a catalyst in the initiation and implementation of joint research, education and service projects between the Institute and the Technion R&D Foundation.